Terms: = Prostate cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Prognosis
61 results:
1. Dishevelled Segment Polarity Protein 3 (DVL3) Induced by Bacterial LPS Promotes the Proliferation and Migration of prostate cancer Cells through the TLR4 Pathway.
Zhang Y; Lin N; Liu X; Yao T
Arch Esp Urol; 2024 Mar; 77(2):193-201. PubMed ID: 38583012
[TBL] [Abstract] [Full Text] [Related]
2. ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression.
Xu H; Li YF; Yi XY; Zheng XN; Yang Y; Wang Y; Liao DZ; Zhang JP; Tan P; Xiong XY; Jin X; Gong LN; Qiu S; Cao DH; Li H; Wei Q; Yang L; Ai JZ
Mil Med Res; 2023 Dec; 10(1):64. PubMed ID: 38082365
[TBL] [Abstract] [Full Text] [Related]
3. Bulk RNA-Seq Combined with Single-Cell Transcriptome Sequencing Reveals the Possible Mechanisms by Which HDGFL3 Involves in prostate cancer Growth and Metastasis.
Xiao C; Liang W
Arch Esp Urol; 2023 Aug; 76(6):425-438. PubMed ID: 37681334
[TBL] [Abstract] [Full Text] [Related]
4. Gleason Score-related MT1L as biomarker for prognosis in prostate adenocarcinoma and contribute to tumor progression in vitro.
Liu L; Li Y; Tang S; Yang B; Zhang Q; Xiao R; Hou X; Liu C; Ma L
Int J Biol Markers; 2023 Jun; 38(2):114-123. PubMed ID: 37192745
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of DDX49 in prostate cancer is associated with poor prognosis.
Tao J; Ge Q; Meng J; Liang C; Hao Z; Zhou J
BMC Urol; 2023 Apr; 23(1):66. PubMed ID: 37106339
[TBL] [Abstract] [Full Text] [Related]
6. P-score in preoperative biopsies accurately predicts P-score in final pathology at radical prostatectomy in patients with localized prostate cancer.
Röbeck P; Xu L; Ahmed D; Dragomir A; Dahlman P; Häggman M; Ladjevardi S
Prostate; 2023 Jun; 83(9):831-839. PubMed ID: 36938873
[TBL] [Abstract] [Full Text] [Related]
7. ARPC5 is transcriptionally activated by KLF4, and promotes cell migration and invasion in prostate cancer via up-regulating ADAM17 : ARPC5 serves as an oncogene in prostate cancer.
Qu G; Zhang Y; Duan H; Tang C; Yang G; Chen D; Xu Y
Apoptosis; 2023 Jun; 28(5-6):783-795. PubMed ID: 36881291
[TBL] [Abstract] [Full Text] [Related]
8. TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell Tumors.
Bacon JVW; Giannatempo P; Cataldo G; Fazli L; Saxena N; Ozgun G; Soleimani M; Chi K; Nichols C; Necchi A; Wyatt AW; Kollmannsberger CK; Nappi L
Oncologist; 2022 Nov; 27(11):e912-e915. PubMed ID: 36166584
[TBL] [Abstract] [Full Text] [Related]
9. [High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer].
Yang M; Zhu X; Shen Y; He Q; Qin Y; Shao Y; Yuan L; Ye H
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1109-1118. PubMed ID: 36073208
[TBL] [Abstract] [Full Text] [Related]
10. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition.
Zhu Y; Peng X; Zhou Q; Tan L; Zhang C; Lin S; Long M
Cell Death Dis; 2022 Apr; 13(4):358. PubMed ID: 35436987
[TBL] [Abstract] [Full Text] [Related]
11. Bisphenol S promotes the progression of prostate cancer by regulating the expression of COL1A1 and COL1A2.
Liu S; He B; Li H
Toxicology; 2022 Apr; 472():153178. PubMed ID: 35405288
[TBL] [Abstract] [Full Text] [Related]
12. GATA binding protein 5-mediated transcriptional activation of transmembrane protein 100 suppresses cell proliferation, migration and epithelial-to-mesenchymal transition in prostate cancer DU145 cells.
Liu J; Lin F; Wang X; Li C; Qi Q
Bioengineered; 2022 Apr; 13(4):7972-7983. PubMed ID: 35358005
[TBL] [Abstract] [Full Text] [Related]
13. Development and validation of a cell cycle progression signature for decentralized testing of men with prostate cancer.
Kuhl V; Clegg W; Meek S; Lenz L; Flake DD; Ronan T; Kornilov M; Horsch D; Scheer M; Farber D; Zalaznick H; Cussenot O; Compérat E; Cancel-Tassin G; Wild PJ; Chun FK; Mandel P; Moinfar F; Cohen T; Delee S; Kronenwett R; Doedt J
Biomark Med; 2022 Apr; 16(6):449-459. PubMed ID: 35321552
[TBL] [Abstract] [Full Text] [Related]
14. Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R).
Li S; Cao L
Bioengineered; 2022 Mar; 13(3):5598-5612. PubMed ID: 34787056
[TBL] [Abstract] [Full Text] [Related]
15. Detection of COX-2 in liquid biopsy of patients with prostate cancer.
Pereira VS; Alves BDCA; Waisberg J; Fonseca F; Gehrke F
J Clin Pathol; 2023 Mar; 76(3):189-193. PubMed ID: 34782424
[TBL] [Abstract] [Full Text] [Related]
16. microRNA-877-5p exerts tumor-suppressive functions in prostate cancer through repressing transcription of forkhead box M1.
Yang B; Diao H; Wang P; Guan F; Liu H
Bioengineered; 2021 Dec; 12(1):9094-9102. PubMed ID: 34654353
[TBL] [Abstract] [Full Text] [Related]
17. FOXO1 inhibits prostate cancer cell proliferation via suppressing E2F1 activated NPRL2 expression.
Tang Y; Jiang L; Zhao X; Hu D; Zhao G; Luo S; Du X; Tang W
Cell Biol Int; 2021 Dec; 45(12):2510-2520. PubMed ID: 34459063
[TBL] [Abstract] [Full Text] [Related]
18. Qi Ling Inhibits Progression of Androgen-Independent prostate cancer via Negative Regulation of TRIM66/HP1γ/AR Axis.
Feng Y; Gao D; Cao H; Chen L
Complement Med Res; 2021; 28(6):492-500. PubMed ID: 34077947
[TBL] [Abstract] [Full Text] [Related]
19. Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer.
Scher HI; Armstrong AJ; Schonhoft JD; Gill A; Zhao JL; Barnett E; Carbone E; Lu J; Antonarakis ES; Luo J; Tagawa S; Dos Anjos CH; Yang Q; George D; Szmulewitz R; Danila DC; Wenstrup R; Gonen M; Halabi S
Eur J Cancer; 2021 Jun; 150():83-94. PubMed ID: 33894633
[TBL] [Abstract] [Full Text] [Related]
20. Vinculin orchestrates prostate cancer progression by regulating tumor cell invasion, migration, and proliferation.
Zheng X; Xu H; Gong L; Cao D; Jin T; Wang Y; Pi J; Yang Y; Yi X; Liao D; Jin X; Wei Q; Yang L; Li H; Ai J
Prostate; 2021 May; 81(6):347-356. PubMed ID: 33710645
[TBL] [Abstract] [Full Text] [Related]
[Next]